Psychedelic Substances Research (Record no. 4237)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03465nas a22003735i 4500 |
| 001 - CONTROL NUMBER | |
| control field | 3059-3689 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | DE-He213 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20260610082530.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 241030s||||||||xxkuu poo|||||| b|EN |d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 3059-3689 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 44451 |
| Source of number or code | local |
| 210 10 - ABBREVIATED TITLE | |
| Abbreviated title | Psychedelic Subst. Res. |
| 245 10 - TITLE STATEMENT | |
| Title | Psychedelic Substances Research |
| Medium | [electronic resource] / |
| Statement of responsibility, etc. | edited by Louis Gautier. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | London : |
| Name of producer, publisher, distributor, manufacturer | BioMed Central : |
| -- | Imprint: BioMed Central. |
| 300 ## - online resource | |
| Other physical details | online resource. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Psychedelic Substances Research is a fully open access, peer-reviewed journal publishing research and commentary on the use of psychedelic substances in medicine, psychology and psychotherapy. Psychedelic substances (also referred to as hallucinogens) are defined as psychoactive substances profoundly alter perception, cognition, mood, and consciousness, often producing changes in sensory experience and self-awareness. The Journal considers applications on all types of psychedelic substances, including purely synthetic compounds (such as LSD), semi-synthetic or naturally derived compounds (such as DMT), naturally occurring compounds (such as psilocybin or mescaline), preparations of plants and fungi with psychedelic properties, and substances that have specific uses in cultural, ritual and religious contexts. Substances that are not classified as hallucinogens but can produce psychedelic effects will be considered (such as ketamine or MDMA). Psychedelic Substances Research provides a resource for informed policy discussion and public discourse on the appropriate use of psychedelic substances in medicine. The journal also aims to inform the organisation of health research systems for psychedelic substances according to current national and international regulations and to foster engagement with differing cultural and religious perspectives on using psychedelic substances more broadly. Psychedelic Substances Research therefore aims to be multidisciplinary and support clinical medicine, psychology, psychiatry, neuroscience, pharmacology, biochemistry and genetics, public health, public policy, traditional medicine, anthropology, and ethnobotany. Examples of therapeutic applications include: Cognitive effects of psilocybin in patients with treatment-resistant depression Impact of psychedelic-assisted therapy on end-of-life anxiety in cancer patients MDMA-assisted psychotherapy for post-traumatic stress disorder (PTSD) Neurobiological mechanisms underlying the antidepressant effects of ketamine Cognitive performance of individuals using regular microdoses of LSD Spiritual and religious practices using ayahuasca for enhancing well-being and personal growth Effectiveness of various psychedelic substances in overcoming addiction or controlling addictive behaviours. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Public health. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Psychiatry. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pharmacology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neuropharmacology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Anthropology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Alternative medicine. |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Public Health. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Psychiatry. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pharmacology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neuropharmacology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Anthropology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Complementary and Alternative Medicine. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gautier, Louis. |
| Relator term | editor. |
| Relationship | edt |
| -- | http://id.loc.gov/vocabulary/relators/edt |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | SpringerLink (Online service) |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://link.springer.com/journal/44451">https://link.springer.com/journal/44451</a> |
| Public note | Open Access |
No items available.